Loskutova L V, Shtark M B, Epstein O I
Institute of Molecular Biology and Biophysics, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk.
Bull Exp Biol Med. 2003 Jan;135 Suppl 7:20-2. doi: 10.1023/a:1024797722719.
We studied the effects of single peroral treatment with antibodies against S100 protein and delta sleep-inducing peptide in ultralow doses on behavioral characteristics of rats with anxious depression produced by acute stress (unavoidable electrical shock). Stress-produced behavioral changes and anxiolytic activity of antibodies were determined using the elevated plus-maze, open field, and tail suspension tests. High efficiency of the mixture of antibodies against S100 protein and delta sleep-inducing peptide was observed in all tests. Anxiolytic activity of anti-S100 antibodies (although less pronounced than that of the mixture of antibodies) was revealed in the elevated plus-maze and tail suspension test.
我们研究了超低剂量的抗S100蛋白抗体和δ睡眠诱导肽单次口服治疗对急性应激(不可避免的电击)所致焦虑抑郁大鼠行为特征的影响。使用高架十字迷宫、旷场试验和悬尾试验来确定应激引起的行为变化以及抗体的抗焦虑活性。在所有试验中均观察到抗S100蛋白抗体和δ睡眠诱导肽混合物具有高效性。在高架十字迷宫和悬尾试验中发现抗S100抗体具有抗焦虑活性(尽管不如抗体混合物明显)。